Sanofi’s not a “colonial company,” says CEO Chris Viehbacher

Chris Viehbacher, Chief Executive Officer (CEO) of Sanofi, signalled his company's continued interest in India as an investment destination and healthcare market in spite of challenges facing foreign-owned pharmaceutical companies in the country such as foreign direct investment (FDI) restrictions and drug price controls. He also drew attention to his company's local manufacturing investments to …

Advertisement

Think different : Big Pharma and drug pricing in emerging markets

I'd like to introduce a guest column by Salil Kallianpur, a healthcare marketing professional with experience in the pharmaceutical and medical devices industries. Salil is an avid reader and follower of healthcare current affairs, its politics, and strategies.  He comments on the intersection of healthcare and life on his blog My Pharma Reviews. He is …